drug

venglustat

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about venglustat: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

3Connections
0Hypotheses
1Analyses
3Outgoing
0Incoming
0Experiments
1Debates

No summary available yet.

View on Wiki →

No AI portrait yet

💊 Drug Info
Namevenglustat
Related DiseasesCNS

Pathway Diagram

flowchart TD
    Venglustat["Venglustat"] -->|"targets"| Lipid_Metabolism["Lipid Metabolism"]
    Venglustat["Venglustat"] -->|"treats"| Parkinson_Disease["Parkinson Disease"]
    Lipid_Metabolism["Lipid Metabolism"] -->|"regulates"| Phospholipid_Peroxidation["Phospholipid Peroxidation"]
    Lipid_Metabolism["Lipid Metabolism"] -->|"modulates"| Ferroptosis["Ferroptosis"]
    Lipid_Metabolism["Lipid Metabolism"] -->|"promotes"| Glioblastoma["Glioblastoma"]
    Lipid_Metabolism["Lipid Metabolism"] -->|"involved in"| Flavivirus_Replication["Flavivirus Replication"]
    Parkinson_Disease["Parkinson Disease"] -->|"risk factor for"| Dementia["Dementia"]
    Parkinson_Disease["Parkinson Disease"] -->|"causes"| Dementia["Dementia"]
    Parkinson_Disease["Parkinson Disease"] -->|"risk factor for"| Dementia_Risk["Dementia Risk"]
    Parkinson_Disease["Parkinson Disease"] -->|"causes"| Cognitive_Impairment["Cognitive Impairment"]
    style Venglustat fill:#6d3000,stroke:#333,color:#e0e0e0
    style Lipid_Metabolism fill:#1b5e20,stroke:#333,color:#e0e0e0
    style Parkinson_Disease fill:#ef5350,stroke:#333,color:#e0e0e0
    style Phospholipid_Peroxidation fill:#1b5e20,stroke:#333,color:#e0e0e0
    style Ferroptosis fill:#5d4400,stroke:#333,color:#e0e0e0
    style Glioblastoma fill:#ef5350,stroke:#333,color:#e0e0e0
    style Flavivirus_Replication fill:#5d4400,stroke:#333,color:#e0e0e0
    style Dementia fill:#ef5350,stroke:#333,color:#e0e0e0
    style Dementia_Risk fill:#5d2900,stroke:#333,color:#e0e0e0
    style Cognitive_Impairment fill:#5d2900,stroke:#333,color:#e0e0e0

Outgoing (3)

TargetRelationTypeStr
Lipid Metabolismtargetspathway0.85
Parkinson Diseasetreatsdisease0.75
CNSassociated_withphenotype0.70

Incoming (0)

SourceRelationTypeStr
No incoming edges

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
No targeting hypotheses

Mentioning Analyses (1)

Scientific analyses that reference this entity

What is the therapeutic window between GCS inhibition efficacy and systemic toxi

neurodegeneration | 2026-04-11 | 0 hypotheses

Experiments (0)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found

Debates (1)

Multi-agent debates referencing this entity

The debate identified systemic toxicity as a major concern for glucosylceramide

closed · Rounds: 4 · Score: 0.50 · 2026-04-20

Related Research

Hypotheses and analyses mentioning venglustat in their description or question text

No additional research found